BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35044058)

  • 21. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
    Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapsed infant MLL-rearranged acute lymphoblastic leukemia with additional genetic alterations.
    Ishida H; Kanamitsu K; Washio K; Muraoka M; Sakakibara K; Matsubara T; Kanzaki H; Shimada A
    Pediatr Blood Cancer; 2016 Nov; 63(11):2059-60. PubMed ID: 27322816
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic and Epigenetic Characterization of a Discordant
    Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
    Pieters R; De Lorenzo P; Ancliffe P; Aversa LA; Brethon B; Biondi A; Campbell M; Escherich G; Ferster A; Gardner RA; Kotecha RS; Lausen B; Li CK; Locatelli F; Attarbaschi A; Peters C; Rubnitz JE; Silverman LB; Stary J; Szczepanski T; Vora A; Schrappe M; Valsecchi MG
    J Clin Oncol; 2019 Sep; 37(25):2246-2256. PubMed ID: 31283407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment strategy for infant acute lymphoblastic leukemia].
    Miyamura T
    Rinsho Ketsueki; 2022; 63(7):791-798. PubMed ID: 35922950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.
    Permikin Z; Popov A; Verzhbitskaya T; Riger T; Plekhanova O; Makarova O; Froňková E; Trka J; Meyer C; Marschalek R; Tsaur G; Fechina L
    Leuk Res; 2022 Jan; 112():106758. PubMed ID: 34864370
    [No Abstract]   [Full Text] [Related]  

  • 27. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.
    Rayes A; McMasters RL; O'Brien MM
    Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Romidepsin enhances the efficacy of cytarabine
    Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
    Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy-induced Deletion in 11q23 Leading to Fusion of
    Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.
    Kemps PG; Cleven AHG; van Wezel T; van Eijk R; Bot FJ; Veelken H; van Balen P; Kerkhoffs JH
    Am J Hematol; 2020 Nov; 95(11):1427-1429. PubMed ID: 32243611
    [No Abstract]   [Full Text] [Related]  

  • 31. Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.
    Wander P; Cheung LC; Pinhanҫos SS; Jones L; Kerstjens M; Arentsen-Peters STCJM; Singh S; Chua GA; Castro PG; Schneider P; Dolman MEM; Koopmans B; Molenaar JJ; Pieters R; Zwaan CM; Kotecha RS; Stam RW
    Leukemia; 2020 Nov; 34(11):2898-2902. PubMed ID: 32488115
    [No Abstract]   [Full Text] [Related]  

  • 32. Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia.
    Driessen EM; Pinhanços SS; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Eur J Cancer; 2016 Apr; 57():87-90. PubMed ID: 26901613
    [No Abstract]   [Full Text] [Related]  

  • 33. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
    Tomizawa D
    Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
    [No Abstract]   [Full Text] [Related]  

  • 34. Infantile leukemia-What factors determine its distinct biological nature? Clinicopathological study of 78 cases.
    Liu X; Zhao Y; Luedke C; Jug R; Yang LH; Lu M; Pan Z; Wang D; Lorsbach R; Shi Y; Knez V; Rehder C; Liang X; Wang E
    Int J Lab Hematol; 2021 Oct; 43(5):1117-1122. PubMed ID: 33847065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new breakpoint fusion gene involving KMT2A::EDC4 rearrangement in de novo acute myeloid leukemia.
    Hu DY; Wang M; Shen K; Pan JL; Guo YS; Zhang ZB; Zhang FH; Yin J; Chen SN
    Int J Lab Hematol; 2023 Aug; 45(4):596-598. PubMed ID: 36811287
    [No Abstract]   [Full Text] [Related]  

  • 36. UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia.
    Zhou X; Zhang P; Aryal S; Zhang L; Lu R
    Leukemia; 2023 Jan; 37(1):226-230. PubMed ID: 36309561
    [No Abstract]   [Full Text] [Related]  

  • 37. Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23);
    Du J; Chisholm KM; Tsuchiya K; Leger K; Lee BM; Rutledge JC; Paschal CR; Summers C; Xu M
    Pediatr Dev Pathol; 2021; 24(4):378-382. PubMed ID: 33749383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lineage switch from acute myeloid leukemia with KMT2A-PTD to mixed phenotype acute leukemia with t(v;11q23).
    Li T; Chen M; Fu M; Wang A; Wang H
    Int J Lab Hematol; 2022 Feb; 44(1):21-22. PubMed ID: 34643033
    [No Abstract]   [Full Text] [Related]  

  • 39. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
    Ikeda J; Shiba N; Tsujimoto SI; Yoshida M; Nakabayashi K; Ogata-Kawata H; Okamura K; Takeuchi M; Osumi T; Tomizawa D; Hata K; Kiyokawa N; Ito S; Kato M
    Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of NG2-positivity for the precise prediction of KMT2A gene rearrangements in childhood acute leukemia.
    Zerkalenkova E; Mikhaylova E; Lebedeva S; Illarionova O; Baidun L; Kashpor S; Osipova E; Maschan M; Maschan A; Novichkova G; Olshanskaya Y; Popov A
    Genes Chromosomes Cancer; 2021 Feb; 60(2):88-99. PubMed ID: 33135273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.